Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol
Post date: Aug 11, 2015 7:31:27 AM
General practitioners (GPs) have a pivotal role in the treatment of COPD patients in primary care. However, the strategies of treatment may differ considerably between individual GPs, resulting in large intra-individual differences in health-care utilisation and quality of life of their patients.
The primary aim of this study is to assess what makes one COPD treatment strategy more cost-effective than others, by taking into account factors related to patients, the physician, and specific follow up and treatment approaches. A secondary objective is to assess whether real-world cost-effectiveness of treatments is comparable between Spain and other countries that have comparable data sets available.